US 11596611
Hepatitis B antiviral agents
granted A61KA61K31/167A61K31/337
Quick answer
US patent 11596611 (Hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/167, A61K31/337, A61K31/34, A61K31/351